Genmab A/S Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$36.73 | $2.92 B | -9.79 | 63 |
ALEC
Alector, Inc. |
$1.01 | $100.08 M | -0.82 | 238 |
AMLX
Amylyx Pharmaceuticals, Inc. |
$3.42 | $303.02 M | -0.77 | 123 |
APLS
Apellis Pharmaceuticals, Inc. |
$19.98 | $2.51 B | -12.48 | 705 |
ASND
Ascendis Pharma A/S |
$142.55 | $8.53 B | -20.22 | 1017 |
BGNE
BeiGene, Ltd. |
$184.71 | $20.21 B | -22.55 | 10600 |
BPMC
Blueprint Medicines Corporation |
$81.75 | $5.22 B | -76.4 | 649 |
CYTK
Cytokinetics, Incorporated |
$37.38 | $4.43 B | -7.11 | 498 |
DAWN
Day One Biopharmaceuticals, Inc. |
$7.23 | $732.80 M | -7.09 | 181 |
EWTX
Edgewise Therapeutics, Inc. |
$11.50 | $1.21 B | -7.93 | 110 |
LEGN
Legend Biotech Corporation |
$31.98 | $2.94 B | -33.31 | 2600 |
MRTX
Mirati Therapeutics, Inc. |
$58.70 | $4.12 B | -4.82 | 587 |
PCVX
Vaxcyte, Inc. |
$31.54 | $4.06 B | -8.3 | 414 |
TERN
Terns Pharmaceuticals, Inc. |
$2.10 | $182.89 M | -1.87 | 59 |
TVTX
Travere Therapeutics, Inc. |
$15.01 | $1.33 B | -3.69 | 385 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
